Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Discover effective ways to quickly boost your income. Take action today and implement strategies that can help you earn more.
23,725 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A Wayfair founder sold shares worth about $2.1 million in February 2026. This article breaks down what insider sellin...
When Nvidia shares stumble, savvy investors look for high-potential AI names that can keep delivering. Here are two s...
What’s going with stock? AMD is riding a data center and AI wave. This guide breaks down the drivers, risks, and real...
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
Berkshire Hathaway is positioned to become a much larger Alphabet holder as the tech giant pursues a bold AI financin...
Could Monero surpass Cardano by 2028? This article lays out the pathways, risks, and strategies for investors trackin...
Tech giants swing on headlines. This guide unpacks why meta stock dropped then, how the rebound happened, and what in...
As Agilent prepares to reveal its Q1 2026 results, investors want clarity on growth signals and margins. This guide b...
The weight loss field is heating up, with Novo Nordisk leading the GLP-1 wave and Amgen pursuing a smaller, more sele...
Investors are weighing Alibaba's prospects after a tough stretch. This guide examines whether alibaba stock rebound c...
A hedge fund recently boosted its position in 10x Genomics, highlighting growing confidence in the biotech tools make...